Role of nanoscale antigen organization on B-cell activation probed using DNA origami
R. Veneziano, T. Moyer, M. B. Stone, T. R. Shepherd, W. R. Schief, D. J. Irvine, M. Bathe
Abstract
Arraying vaccine immunogens in a multivalent form on the surface of virus-like particles is an important strategy used to enhance the efficacy of subunit vaccines. However, the impacts of antigen valency, spacing, and spatial organization on B cell triggering remain poorly understood. Here, we use DNA origami nanoparticles to create precise nanoscale organizations of a clinically-relevant HIV gp120 immunogen to systematically interrogate their impact on B cell triggering in vitro. We find that antigen dimers elicit monotonically increasing B cell receptor activation as inter-antigen spacing increases up to ~30 nm, and only 5 immunogens arrayed on the surface of a 3D particle are needed to elicit maximal B cell calcium signaling. Our results reveal design principles of viral and immunogen display that drive functional B cell responses.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA origami vaccines program antigen-focused germinal centers
Anna M. Romanov, Grant A. Knappe, … Darrell J. Irvine·SciencePeer-reviewed·Feb 5, 2026
- Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
E.-C. Wamhoff, L. Ronsard, … M. Bathe·bioRxiv·Aug 16, 2022
- Targeting HIV Env immunogens to B cell follicles in non-human primates through immune complex or protein nanoparticle formulations
J. T. Martin, C. T. Cottrell, … D. J. Irvine·bioRxiv·Feb 19, 2020
- Fine tuning of CpG spatial distribution with DNA origami for improved therapeutic cancer vaccination
Yang C. Zeng, Olivia J. Young, … William M. Shih·bioRxiv·Jun 8, 2022
- Duality Vaccination through Nanodesign of Click-Ligated B-Cell Inhibitory Receptor Bridging
Gabrielle Admans, Rory A. Hills, … Mark R. Howarth·bioRxiv·Oct 30, 2026
- Molecular basis for potent B cell responses to antigen displayed on particles of viral size
J. F. Brooks, J. Riggs, … J. Zikherman·bioRxiv·Feb 15, 2023